Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients
Clinical trial NCT02190604 · TERMINATED
Trial details
- NCT number
- NCT02190604
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-31
- Primary completion
- 2015-11-30
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.